ESR1 and ovarian cancer: Furthermore, since Tamoxifen and ICI 182780, antagonists to nuclear ERs, and G-1, a specific GPER agonist, mimicked this effect of estradiol, we concluded that estrogen modulation of EGF induced migration in ovarian cancer cells was mediated by GPER, not by ERα.